Efficacy and safety of nab-paclitaxel in patients with metastatic breast cancer: Final results of the non-interventional study NABUCCO

被引：0
|
作者：
Marschner, N.
Potthoff, K. [1 ]
Salat, C.
Soeling, U.
Hansen, R.
Grebhardt, S. [1 ]
Horde, J. [1 ]
Nusch, A.
机构：
[1] iOMEDICO AG, Freiburg, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2016年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P598
引用
收藏
页码：183 / 183
页数：1
相关论文
共 50 条
  • [11] Clinical efficacy of nab-paclitaxel in patients with metastatic pancreatic cancer
    De Luca, Rossella
    Blasi, Livio
    Alu, Massimiliano
    Gristina, Valerio
    Cicero, Giuseppe
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 1769 - 1775
  • [12] Efficacy and safety of Nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer
    Filipazzi, V.
    Dalu, D.
    Isabella, L.
    Tosca, N.
    Ferrario, S.
    Gambaro, A.
    Somma, L.
    Fasola, C.
    Pellegrini, I.
    Bombonati, G.
    Curcio, R.
    Damiani, E.
    Cattaneo, M. T.
    ANNALS OF ONCOLOGY, 2017, 28
  • [13] EFFICACY AND SAFETY OF NAB-PACLITAXEL IN COMBINATION WITH GEMCITABINE FOR METASTATIC PANCREATIC CANCER
    You, Min Su
    Ryu, Ji Kon
    Kang, Jinwoo
    Choi, Jin Ho
    Choi, Young Hoon
    Huh, Gunn
    Paik, Woo Hyun
    Lee, Sang Hyub
    Kim, Yong-Tae
    GASTROENTEROLOGY, 2018, 154 (06) : S285 - S285
  • [14] Comparison of nab-paclitaxel plus gemcitabine in elderly versus younger patients with metastatic pancreatic cancer: Analysis of a multicentre, prospective, non-interventional study
    Prager, Gerald W.
    Oehler, Leopold
    Gerger, Armin
    Mlineritsch, Brigitte
    Andel, Johannes
    Petzer, Andreas
    Wilthoner, Klaus
    Sliwa, Thamer
    Pichler, Petra
    Winder, Thomas
    Heibl, Sonja
    Gruenberger, Birgit
    Laengle, Friedrich
    Hubmann, Eva
    Korger, Markus
    Pecherstorfer, Martin
    Djanani, Angela
    Neumann, Hans-Joerg
    Philipp-Abbrederis, Kathrin
    Woll, Ewald
    Trondl, Robert
    Arnold-Schrauf, Catharina
    Eisterer, Wolfgang
    EUROPEAN JOURNAL OF CANCER, 2021, 143 : 101 - 112
  • [15] Nab-paclitaxel utilization pattern and safety profile in patients with metastatic breast and pancreatic cancer
    Cortes de Miguel, S.
    Ruiz Fuentes, S.
    Belda Rustarazo, S.
    Valle Corpas, M.
    Casas Hidalgo, I.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2016, 38 (02) : 507 - 507
  • [16] Efficacy and safety of nab-paclitaxel in metastatic gastric cancer: a meta-analysis
    Ahmad, Suhana
    Lambuk, Lidawani
    Ahmed, Naveed
    Mussa, Ali
    Tee, Vincent
    Idris, Ros Akmal Mohd
    Sahran, Nur Fazimah
    Chan, Yean Yean
    Hassan, Rosline
    Lee, Yeong Yeh
    Mohamud, Rohimah
    NANOMEDICINE, 2023, 18 (24) : 1733 - 1744
  • [17] A Real-World Efficacy of Nab-Paclitaxel Monotherapy in Metastatic Breast Cancer
    Kim, Jung Sun
    Suh, Koung Jin
    Lee, Dae-Won
    Woo, Go-Un
    Kim, Miso
    Kim, Se Hyun
    Ryu, Han Suk
    Lee, Kyung-Hun
    Kim, Tae-Yong
    Han, Sae-Won
    Park, So Yeon
    Park, In Ae
    Kim, Jee Hyun
    Im, Seock-Ah
    CANCER RESEARCH AND TREATMENT, 2022, 54 (02): : 488 - 496
  • [18] nab-Paclitaxel for the Treatment of Aggressive Metastatic Breast Cancer
    Glueck, Stefan
    CLINICAL BREAST CANCER, 2014, 14 (04) : 221 - 227
  • [19] Nab-paclitaxel in pretreated metastatic breast cancer: evaluation of activity, safety, and quality of life
    De Luca, Rossella
    Profita, Giuseppe
    Cicero, Giuseppe
    ONCOTARGETS AND THERAPY, 2019, 12 : 1621 - 1627
  • [20] NAB-Paclitaxel Plus Carboplatin As First-Line Therapy for Patients with Advanced NSCLC in the Real-World Setting: Safety Results of the Non-Interventional Neptun Study
    Dechow, Tobias
    Riera-Knorrenschild, Jorge
    Hackanson, Bjoern
    von Weikersthal, Ludwig Fischer
    Chiabudini, Marco
    Timm, Barbara
    Zerbes, Ralf Michael
    Potthoff, Karin
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 112 - 112
12345